Here's a snippet from Levi Weaver's most recent Ranger update in the Athletic about Garver.
Garver's injured forearm flexor means he won't catch again this season. Much like
Shohei Ohtani's recovery from Tommy John surgery, Garver can still swing a bat, but he can't throw. Worse yet, the time spent on the COVID-19 IL stiffened his arm, making it even more uncomfortable. This presents the Rangers with a conundrum: Garver says he can't be the player he wants to be without surgery, so the front office has to decide if keeping his bat in the lineup is worth the cost of him missing some of the 2023 season or if it's better to pull the trigger on the procedure now so he can be fully healthy and ready to go for next season.
"You know, it's not ideal," Garver said, clearly frustrated. "The front office knows about it, the staff knows about it. I mean, it's not really a big secret at this point. We're trying to do the best we can to manage it."
While surgery seems inevitable, the
when might be dictated by the performance of the team. The Rangers have been lingering on the outskirts of wild-card contention for over a month. If they surge into late-season relevance, Garver's presence in the lineup could provide value as they chase their first postseason appearance since 2016. If they wilt, there's no point in mortgaging 2023 for meaningless games this season.
"If we do have to go down that road, then we have to decide where we're at in the standings," said manager Chris Woodward. "If it's a pretty steep mountain to climb, then it probably wouldn't make sense to hang on. But if we're on a tear, pull off seven or eight in a row, or just somehow get into a really good position, that's a much tougher decision. And you never know. If you've got an opportunity, a chance to win the bracket, if we pull it off, I think he'd probably want to be a part of that."
Another factor is whether Garver's production is going to warrant sticking around. While he hit well before going on the COVID IL, he's 1-for-9 since returning. "I'm not hitting the ball well," Garver said. "I'm not gonna blame it on my elbow; I'm just not hitting the ball well, and it is what it is. But I do think (the elbow stiffness) is part of it. (It) sucks not being able to catch. It's who I am. I'm not a DH, I'm a catcher. So a big part of who I am is missing if I can't go out there and do what I want to do and do what I'm good at."
It does help that the Rangers
have catching depth, even after trading
Jose Trevino to the Yankees.
Jonah Heim has always been an above-average defender and pitch-framer at the position, but this year, he has emerged as a perfectly serviceable every-day big-leaguer, hitting .246/.307/.474 (.781 OPS) with 10 home runs. And while Sam Huff is back in Triple A to get more playing time, he's still considered a part of the team's future plans and could be paired with Heim, whether that's this year or next. After that, there's
Meibrys Viloria, who is currently in the big leagues, and Yohel Pozo, who hit well in Arlington in 2021. Further down the depth chart, David Garca is a highly-regarded prospect, though he's still a ways from being big-league ready.
But they'll have to make that decision soon. Surgery requires recovery time, and if the team wants Garver at full strength by spring training, that presents a deadline. Full recovery is usually around six to eight months (though Garver could return to a DH-only role sooner). That would mean the surgery would need to occur between about two weeks ago and the middle of August. The earlier they decide, the more wiggle room they give themselves to deal with any complications or setbacks.